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Contribution of dialysate acetate to energy metabolism: Metabolic
implications. During hemodialysis large amounts of acetate enter the
bloodstream. Generally, it is assumed that this exogenous acetate load
is oxidized immediately to carbon dioxide and water; however, the rate
of plasma acetate oxidation and the effect of acetate oxidation on
energy metabolism during hemodialysis has not been determined previ-
ously. The rates of plasma acetate turnover and oxidation were
determined during hemodialysis in seven chronic renal failure patients
by the primed continuous infusion of [l—'4C1 acetate. The plasma
acetate turnover rate (57.2 2.9 zmoles/min kg) agreed closely with
the mass transfer rate of dialysate acetate into the bloodstream (55.3
3.2 moles/min . kg). Of the acetate entering the bloodstream, 54.5
5.2% or 31.6 3.77 zmoles/min kg was oxidized immediately ac-
counting for 40.3 4.8% of the patient's caloric expenditure. Although
the oxidation of acetate during dialysis supplied a major portion of the
patient's caloric need, a significant quantity of acetate was eliminated
by pathways other than direct oxidation. An average overall respiratory
quotient (RQ) of 1.0 0.02 indicated that fat oxidation was spared to
maintain energy homeostasis during hemodialysis. The calculated non-
protein RQ exceeded unity suggesting that net fat synthesis actually
occurred.
Contribution d'un dialysat avec acetate au métabolisme énergétique:
Implications metaboliques. Pendant l'hémodialyse, de grandes quantités
d'acétate entrent dans le courant sanguin. On estime en général que
cette charge en acetate exogene est immédiatement oxydee en dioxyde
de carbone et en eau; cependant la vitesse d'oxydation de l'acétate
plasmatique et l'effet de l'oxydation de l'acétate sur le métabolisme
énergetique pendant l'hemodialyse n'Ont pas été déterminés aupara-
vant. Les vitesses de renouvellement et de l'oxydation de l'acétate
plasmatique ont été déterminées pendant l'hemodialyse chez sept
malades en insuffisance rénale chronique par perfusion continue après
dose de charge de [1 — 14C1 acetate. La vitesse de renouvellement de
l'acétate plasmatique (57,2 2,9 moles/mn . kg) était en ëtroite
concordance avec Ia vitesse de transfert massique de l'acétate du
dialysat vers le courant sanguin (55,3 3,2 zmo1es/mn kg). De
l'acétate entrant dans le courant sanguin, 54,5 5,2% ou 31,6 3,77
imoles/mn . kg, étaient immédiatement oxydes, cc qui représentait
40,3 4,8% de Ia depense calorique du malade. Bien que l'oxydation de
l'acétate pendant Ia dialyse contribue a une trés grande partie du besoin
calorique des malades, une quantité significative d'acétate était utilisée
par d'autres voies que l'oxydation directe. Un quotient de Ia respiration
(QR) global moyen de 1,0 0,02 indiquait que l'oxydation des graisses
était épargnée pour maintenir l'homéostasie energetique pendant l'hé-
modialyse. Le QR nonprotéique calculé depassait l'unité, cc qui
suggérait qu'une synthèse nette de graisse s'est véritablement produite.
bicarbonate stores, acetate, a short-chain fatty acid, would be
expected to be a source of energy. However, there is virtually
no quantitative data available, to our knowledge, concerning its
role as an energy source in the dialysis patient because it has
not been possible to quantify explicitly the amount of acetate
oxidized immediately via the Kreb's tricarboxylic acid cycle
which is a prerequisite for computing the energy yield from
acetate oxidation. Tolchin et al [1] attempted to estimate the
amount of acetate oxidized to carbon dioxide and water during
dialysis by measurement of the bicarbonate generation rate
from acetate; however, the bicarbonate generation rate cannot
be equated with the rate of acetate oxidation via the Kreb's
cycle. Bicarbonate generation occurs by equimolar proton
consumption when acetate becomes activated by acetyl CoA
synthetase to form acetyl CoA, but before acetyl CoA has
entered the Kreb's cycle. Besides the Kreb's cycle, acetyl CoA
can enter several divergent metabolic pathways such as the
formation of ketoacids, pyruvate, fatty acids, cholesterol, and
amino acids. Hence, bicarbonate generation is actually only a
measure of acetyl CoA formation and not a measure of the
direct oxidation of acetate. Davidson et al attempted to measure
acetate oxidation by infusing [l—14C] acetate during acetate
dialysis in dialysis patients [2], and Morin et al attempted the
same procedure in uremic dogs [31. They found that approxi-
mately 70 to 80% of the administered radioactivity was collect-
ed as '4C02 over a 20-hr period. These studies measured carbon
flow but did not determine either the fraction of the acetate
turnover oxidized or the contribution of acetate to energy
metabolism during hemodialysis. Because of the long duration
of these studies, the '4C02 generated may not have arisen
directly from the oxidation of radioactive acetate, and hence
may not indicate the oxidation rate of acetate either during or
after hemodialysis. The '4C02 could have come from other
substrates such as glucose, free fatty acids, ketoacids, or amino
acids that were synthesized from labeled acetyl CoA and then
reconverted to acetyl CoA during subsequent oxidative metab-
olism. Also, in those studies, the plasma acetate and expired
Interest in acetate metabolism during dialysis has focused on
the role of acetate in acid-base balance and its alleged adverse
side effects. Although dialysate acetate is given to replenish
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Table 1. Clinical data of subjects
59 M 66.4 4 hr; 3 )< wk
2 58 M 72.2 4 hr; 3 x wk
3 42 F 58.6 4 hr; 3 x wk
4 72 F 72.6 4 hr; 3 x wk
5 38 F 6t).9 4 hr; 3 x wk
6 53 F 56.5 3 hr: 3 x wk
7 71 M 54.4 3 hr; 3 x wk
8 58 M 71.6 4 hr; 2 x wk
9 34 M 79.1 4 hr; 3 x wk
10 66 M 61.3 3 hr; 3 x wk
The surface area of each dialyzer is expressed in square meters.
Period
of
carbon dioxide specific activities were not determined. Thus,
the quantity of acetate entering the body that was oxidized
immediately to carbon dioxide and water could not he calculat-
ed using precursor product relationships, Consequently, neither
the rate of acetate oxidation nor the energy yield from acetate
oxidation during dialysis could be computed.
In contrast, the present studies were designed to measure the
rates of plasma acetate turnover and immediate oxidation using
previously validated constant infu sion radioisotope dilution
techniques in conjunction with indirect calorimetry. In addi-
tion, acetate mass transfer was measured directly and com-
pared to the isotope method. The results show that plasma
acetate emerges as a major energy yielding metabolic fuel
during acetate dialysis. Therefore, it is likely that the oxidation
of other metabolic substrates underwent alterations to maintain
energy homeostasis.
Methods
Six male and four female stable hemodialysis outpatients
ranging from 34 to 72 years old were studied (Table 1). The
etiologies of their chronic renal failure arc shown in Table 1.
Patients numbered I through 4 were established hemodialysis
patients whereas the remainder of the patients had undergone
hemodialysis treatment for 2 months or less.
Patients 6 and 9 fasted overnight, and patient 10 had breakfast
at home 3 hr before the study. The remainder of the patients
consumed breakfast which consisted of approximately 750 keal
during the first hour of hemodialysis.
The patients were dialyzed using hemodialyzers in the single
pass mode against a commonly used dialysis bath that con-
tained 37 mmoles acetate, 12.4 mmolcs glucose, 130 mEq
sodium, 2.5 mEq calcium, 2.0 mEq potassium, 1.5 mEq magne-
sium, and 99 mEq chloride per liter. The concentration of
acetate was verified by enzymatic analysis. The type of dialyzer
used is shown in Table I. Access routes were either a Quinton
Seribner shunt (patients 2, 3, and 5), arteriovenous fistula
(patients 9, 6, and 10), or a Gortex graft (patient 7). During
hemodialysis, blood and dialysis fluid flow rates were estab-
lished at 200 and 500 mI/mm, respectively. A Drake Willock
model #4500 blood pump was used and calibrated by either in
vitro volumetric collection or bubble transit time using a 50-cm
race track. Neither positive nor negative pressures were applied
to minimize the ultrafiltration rate. Dialysate how rates were
verified by volumetric calibration. In each patient, the metabol-
ic studies were performed during the dialysis procedure 2 days
after the prior dialysis. At the time of the study, each patient
was considered to be in a stable hemodynamic state and had
consented voluntarily after a thorough explanation of the
procedure.
The rates of plasma acetate turnover and oxidation were
determined in all but patients 1, 4, and 8 by the primed
continuous infusion of 75 1.tCi of [l—14C1 acetate, sp act 2.5
mCi/mmole (Amersham/Searle Corp., Arlington Heights, Illi-
nois), over the dialysis period. The validity of the assumptions
in the use of constant infusion isotope dilution methods to
determine plasma substrate turnover and oxidation rates has
been reviewed extensively [4]. The ratio of priming dose
(microcuries) to infusion rate (iCi/min) was 50. The isotope
was infused into the venous return line of the hemodialyzer.
Starting at the second hour of dialysis, samples of heparinized
blood were taken hourly from the arterial line and the venous
line of the dialyzer upstream from the site of Ii — 4C] acetate
infusion. A polyethylene catheter was inserted into an opposite
antecubital arm vein of patients with either a fistula or graft
from which hourly blood samples were withdrawn in conjunc-
tion with those taken from the arterial and venous lines of the
dialyLer. With each hourly withdrawal of blood, a 20-ml aliquot
of dialysis fluid was collected anaerobically to measure the
carbon dioxide and bicarbonate concentrations in the dialysis
fluid by standard fluid gas procedures using a blood gas
analyzer (IL. Model 813)'. An additional deciliter of dialysis
fluid was alkalinized with 2 ml of 1.0 N NaOH. An aliquot of the
alkaline fluid was acidified and the liberated 4C02 was collect-
ed in 2:1 Hyamine - methanol and counted in a Tri-Carb
spectrometer. Samples of breath were also collected hourly in
bags (I)ouglas) as described by Issekutz et al 161. The oxygen
and carbon dioxide content of the expired air was measured
hourly with a diaferometer (Noyons) [71 and the expired 4C02
'The titrametric and Natelson microgasometer techniques for the
measurement of bicarbonate in nonprotein-containing fluids are report-
edly 15] more accurate than the blood gas analyzer at bicarbonate
concentrations exceeding 20 m. However, the differences between
these techniques are negligible at the dialysate bicarbonate concentra-
tions (8 mM) encountered during acetate hemodialysis.
Patient Age Weight Dialysis dialysis
no, yr Sex kg protocol months Dialyzer" Diagnosis
56 Garnbro (1.5) Malignant hypertension
46 Gambro (1.5) Polycystic kidneys
35 'Fri Ex (1.0) Chronic glomerulonephritis
7 CF (1.5) Nephrosclerosis
2 Tn Ex (1.0) Diabetic nephropathy
2 Tn Ex (1.0) Chronic glomerulonephritis
I Tn Ex (I .0) Nephrosclerosis
I CF (1.2) Chronic glomerulonephritis
1.5 Tn Ex (1.0) Chronic glomerulonephnitis
0.5 Tn Ex (1.0) Polycystic kidneys








was measured, as described by Fredrickson and Ono [8]. An
ultrafiltrate of plasma was prepared through membranes with a
nominal molecular weight cut-off of 10,000 (Millipore Corp.,
Bedford, Massachusetts). The ultrafIltrate was diluted with
deionized water and an aliquot of the diluted ultrafiltrate was
taken for the enzymatic determination of acetate [9]. [1— '4C]
acetate was isolated from 1 ml of ultrafiltrate by the distillation-
diffusion procedure of Bartley [101.
The quantity of acetate that diffused into the plasma per unit
time of hemodialysis was determined from the plasma acetate
concentration difference (A-V) between the arterial blood enter-
ing the dialyzer and the venous return leaving the dialyzer
multiplied by the plasma flow rate2.
Isotope calculations. To calculate the immediate oxidation of
plasma acetate during hemodialysis, the carbon dioxide specific
activity must be corrected to a value that represents complete
21n preliminary experiments, no significant difference was found in
the method of determination of acetate mass transfer by either the A-V
blood acetate concentration difference multiplied by blood flow rate or
the A-V plasma acetate concentration difference multiplied by the
plasma flow rate.
isotope equilibration in the bicarbonate pool. During the con-
stant infusion of tracers, the specific activity (SA) of exhaled
'4C02 and the percent recovery of '4C02 rise in an exponential
way and with time approach asymptotically a constant value.
This curvilinear rise is due to the relatively slow diffusion (and
hence retention) of '4C02 derived from tissue oxidation into the
large unlabeled bicarbonate pool as well as exhalation from the
lungs. The asymptotic value of the specific activity SA
['4C02] represents the ideal situation in which the SA of
'4C02 in exhaled air has the same specific activity as
arising from tissue oxidation. Issekutz et al [6] have shown that
SA '4CO2 at any time, t, can be corrected to the ideal SA
'4CO2. This is accomplished by a constant infusion of
NaH'4C03 and obtaining a curve by plotting the ratio of
recovered exhaled '4C02 to infused NaH14CO3 (fractional re-
covery of 14C02) versus time. Then '4CO2SA = '4CO2SAI
(Rh)1 where (RhI) is obtained from the curve. Implicit is the
assumption that '4C02 derived from tissue oxidation of the
tracer, [l—'4C] acetate would not be recovered any more
rapidly than the recovery of 14C02 from the conversion of
NaH'4C03 to 14CO2. The correction curve is obtained as
follows: A constant infusion of 25 Ci of NaH'4C04 SA 8.4
mCi/mmole (Amersham/Searle Corp., Arlington Heights, Illi-
nois) was administered during hemodialysis to the subjects
listed in Table 1 with the exception of patients 5 and 6. The rate
of carbon dioxide that appeared in the breath and the rate that
the carbon dioxide plus bicarbonate was lost to the dialysis fluid
was determined at 30-mm intervals during the first hour and
hourly thereafter. The ratio of the rates that '4C02 and '4C02
plus 4C-bicarbonate appeared in the breath and dialysis fluid,
respectively, to the rate of NaH'4C03 infusion was referred to
as the fractional recovery of the NaH'4C03 infusion rate (Fig.
1). The fractional recovery of the NaH'4C03 infusion rate in
both the breath and dialysis fluid approached constant values of
0.53 and 0.22, respectively, between the third and fourth hours
of hemodialysis.
The period between the infusion of NaH'4C03 and [l—14C1
acetate was at least 7 days. Both the NaH'4C03 and the [l—'4C]
acetate were infused after a 2-day interdialytic period so that
the bicarbonate pool size was essentially the same during either
infusion. During the infusion of [l—'4C] acetate, the '4C02
output was corrected to complete isotopic equilibration, as
described above, to calculate the carbon dioxide specific activi-
ty using the breath plus dialysate fractional recovery curve in
Figure 1.
The following equations as previously described [9] were
used to calculate the rates of plasma acetate turnover and
oxidation:
Plasma acetate turnover (lLmoles/min .kg) = (Ij
[1'4C] acetate infusion rate (Ci/min)
Plasma acetate specific activity (xCi/Lmole) x body wt (kg)
The arterial plasma acetate specific activity was used in patients
with shunts and peripheral venous plasma acetate specific
activity was used in patients with fistulas and grafts.
% CO2 from plasma acetate oxidation =
CO2 specific (corrected) x 2
< 100
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Fig. 1. Fractional recovery of NaH14CO3 infusion rate in the dialysate
'CO2 plus '4C-bicarbonaie, the expired '4C02, and the expired breath
14C02 and dialysate '4C02 plus '4C-bicarbonate during hemodialysis.
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Plasma acetate oxidation rate (imoles/min kg)
% CO2 from plasma acetate oxidation x CO2 output
2 >< body wt (kg)
% Plasma acetate turnover oxidized =
Plasma acetate oxidation rate
x 100.Plasma acetate turnover rate
Results
During hemodialysis carbon dioxide was lost from the body
by normal pulmonary expiration and by the diffusion of dis-
solved carbon dioxide and bicarbonate from the blood into the
dialysis fluid. The dialysate carbon dioxide output shown in
Table 2 is the sum of the dissolved carbon dioxide and bicarbon-
ate passing into the fluid. Because the oxygen consumption and
carbon dioxide output did not fluctuate significantly during
dialysis, the hourly values obtained for each subject were
averaged and the mean values are presented in Table 2. The rate
of carbon dioxide production in the breath was approximately
threefold greater than the rate of carbon dioxide plus bicarbon-
ate lost in the dialysis fluid. For all the subjects, the mean rate
of breath carbon dioxide production was 7,24 0.43 mmoles/
mm (range, 4.49 to 9.15) compared to 2.52 0.07 mmoles of
carbon dioxide plus bicarbonate per minute (range, 2.10 to 2.75)
lost to the dialysis fluid. This amount lost through the dialyzer is
similar to the 3 mmoles/min carbon dioxide loss found by Dolan
et al [11]. It was possible, therefore, to calculate two respiratory
quotient (RQ) values for our patients during hemodialysis.
Based solely on the breath carbon dioxide output, the mean RQ
was 0.74 0.01; however, by including the dialysate carbon
dioxide plus bicarbonate output, the mean RQ (adjusted RQ)
rose to 1.00 0.02.
The rates of oxygen consumption and carbon dioxide produc-
tion were determined in five patients at rest as well as during
acetate hemodialysis with glucose. At rest the observed RQ of
these patients was 0.85 0.02 (mean 5EM) which increased to
1.12 0.06 during dialysis. In the resting state and during
(3) dialysis, the mean rates of breath carbon dioxide production
(6.56 0.69 mmoles/min vs. 7.16 mmoles/min) and oxygen
consumption (8.39 0.85 mmoles/min vs. 8.64 0.89 mmoles/
mm) did not differ significantly. Thus, the increase in the RQ
during acetate dialysis with glucose resulted primarily from the
diffusion of carbon dioxide and bicarbonate into the dialysis
fluid and not to a change in oxygen consumption. Dolan et at
[lii observed a reduction in breath carbon dioxide production
during acetate dialysis. A possible explanation for their obser-
vation is that their patients were dialyzed with a glucose-free
dialy sate.
Prior to hemodialysis the patients had normal plasma acetate
levels [91 ranging from 0.058 to 0.137 m (Table 3). Within 2 hr
of the onset of hemodialysis the arterial plasma acetate concen-
tration was elevated from 18 to 70-fold and remained constant
for the remainder of the dialysis period. The mean arterial levels
were 3.92 0.58 mM. Constancy of blood levels in this range
during dialysis indicated that the capacity to utilize acetate was
not exceeded. A constant plasma acetate specific activity was
also achieved by the second hour of hemodialysis indicating
that steady state conditions were established (Table 3). The
rates of plasma acetate turnover and oxidation (Table 4) were
calculated from the hourly specific activities shown in Table 3.
In addition, the rates of plasma acetate uptake from the dialysis
bath were determined at the second hour and hourly thereafter,
and the average hourly rates of plasma acetate turnover,
oxidation, and uptake in each patient during hemodialysis are
shown in Table 4.
The rates of acetate uptake from the dialysis bath as deter-
mined by the plasma acetate A-V difference ranged from 45.3
zmoles/min kg in patient 9 to 70.7 moles/min kg in patient 5
(Table 4). The overall mean acetate uptake for the seven
patients was 55.3 3.2 moles/min kg which is comparable to
that reported by others [1, 12—14] using similar dialysis condi-
tions. Plasma acetate turnover as determined by the radioiso-
tope dilution technique is the sum of the endogenous plasma
acetate production and the uptake of acetate in the plasma from
the dialysis bath. The plasma acetate turnover rates (Table 4)
agreed closely with the rate of acetate uptake from the dialysis
rnmo!es/,nin
Table 2. Mean oxygen consumption, carbon dioxide output, RQ, and resting caloric expenditure during hemodialysis
Breath CO2 Dialysate CO2
consumption output output Caloric
Adjusted expenditure
Patient no. RQ RQ5 kcal/24 hr ' kg
11.47 7.47 2.72 0.65 0.89 25.5
2 9.56 6.77 2.53 0.71 0.97 20.0
5 10.07 6.83 2.54 0.68 0.93 24.7
3 10.53 8.70 2.21 0.83 1.03 27.2
7 9.45 6.97 2.47 0.74 0.99 26.3
4 8.09 6.10 2.45 0.75 1.06 19.4
8 10.07 7.36 2.75 0.73 1.00 21.3
9 12.23 9.15 2.70 0.75 0.97 22.9
6 6.07 4.49 2.10 0.74 1.09 16.3
10 10.40 8.53 2.70 0.82 1.08 25.8
Mean 5EM 9.79 0.55 7.24 0.43 2.52 + 0.07 0.74 0.01 1.00 0.02 22.9 1.1
a RQ is the ratio between the breath carbon dioxide output and the oxygen consumption.
Adjusted RQ is the ratio between the sum of the breath carbon dioxide and the dialysate carbon dioxide plus bicarbonate output and the oxygen
consumption.
"The caloric expenditure is estimated from the oxygen uptake and the adjusted RQ.
bath which indicated that endogenous plasma acetate produc-
tion was negligible during hemodialysis.
Of the acetate entering the body during dialysis, 31.6 3.77
tmoles/min kg were immediately oxidized to carbon dioxide
and water which accounted for 54.4 5.2% of the turnover rate
(Table 4). In six of the seven patients studied, less than 60% of
the exogenous acetate load was oxidized immediately. A signifi-
cant amount of acetate, therefore, must be eliminated by
pathways other than direct oxidation.
The mean weight of the patients included in this study was
63.3 kg. During a 4-hr dialytic period, therefore, the exogenous
acetate load was approximately 869 mmoles. Assuming that
acetate was dispersed homogeneously in total body water
which is 60% of the body weight, the average acetate space was
63.3 X 0.6 = 37.98 liters. If the acetate concentration in the
space was 3.6 m, then the acetate pool was 3.6 mmoles/liter x
37.98 liters = 138 mmoles. Of the 869 mmoles of acetate that
entered the bloodstream during dialysis, approximately 473
mmoles (54.4%) were oxidized immediately to carbon dioxide
and water, 138 mmoles comprised the acetate pooi, and 258
mmoles were eliminated by pathways other than direct
oxidation.
The resting caloric expenditures of the patients studied
during hemodialysis were within normal limits (Table 2); how-
ever, a major portion of their caloric requirement was satisfied
by the oxidation of plasma acetate (Table 4). Ordinarily plasma
acetate is not an important fuel contributing less than 10% of the
caloric requirement [9], but during dialysis its oxidation ac-
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Table 3. Plasma acetate concentrations before and during hemodialysis and plasma acetate specific activities during hemodialysis











Arterial mMa 3.79 4.09 3.53 3.80
SA" 0.050 0.047 0.055 0.051
Venous mM 0.101 27.9 29.6 27.5 28.3
Arterial m 3.79 4.07 4.38 4.08
SA 0.060 0.049 0.051 0.053
Venous m 0.058 32.5 36.0 35.5 34.7
Arterial m 3.36 3.55 3.81 3.57
SA 0.069 0.066 0.067 0.067
Venous mM 0.137 31.4 28.3 25.7 28.5
Arterial m 2.46 2.43 2.45
Venous mM 24.5 25.0 24.8
P-Venous mMd 0.064 2.12 2.09 2.11
SAc 0.099 0.103 0.101
Arterial ms 1.77 1.79 1.89 1.82
Venous m 23.6 24.4 22.1 23.4
P-Venous m 0.100 1.07 1.07 1.10 1.08
SA 0.041 0.046 0.053 0.047
Arterial m 5.81 5.56 5.69
Venous m 26.7 27.4 27.1
P-Venous m 0.137 5.63 5.53 5.58
SA 0.060 0.076 0.068
Arterial m 5.18 6.20 6.61 6.00
Venous ms 26.1 24.7 27.5 26.1
P-Venous m 0.097 4.86 5.40 5.43 5.23
SA 0.050 0.052 0.057 0.053
0.100±
0.010
a Plasma acetate concentration in the arterial blood entering the dialyzer.
b Plasma acetate specific activity expressed as nanocuries of 1 — 14C acetate per micromole acetate in the arterial blood entering the dialyzer.
a Plasma acetate concentration in the blood leaving the dialyzer and entering the vein of the patient.
d Peripheral venous plasma acetate concentration.
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Table 4. Plasma acetate turnover and oxidation during hemodialysis
Plasma acetate Turnover oxidized
____________________ — CO2 output
Uptake' Turnover pinoleslntin kg 9k from
acetate
Patient no. pino/es/tnin kg oxidation %
2 51.5 60.4 36.t) 59.6 47.1
3 59.5 58.0 30.0 51.7 35.4
5 70.7 62.8 5t).5 80.5 65.4
6 51,5 49.9 17.4 34.9 34.2
7 59.2 59.5 30.3 50.9 34.7
9 45.3 43.6 21.7 49.7 26.6
10 49.3 65.9 35.5 53.8 38.4
Mean SEM 55.3 3.2 57.2 2.9 31.6 + 3.77 54,4 5.2 40.3 4.8
a Uptake is defined as the plasma acetate concentration difference between the arterial blood entering the dialyzer and the venous blood leaving
the dialyzer multiplied hy the plasma flow rate.
'Percent of the plasma acetate lurnover rate that is oxidized immediately.
counted for 40.3 4.8% of the carbon dioxide output or 40.3
4.8% of the metabolic rate. Therefore, during hemodialysis
plasma acetate emerged as a major, and probably the major,
contributor to energy homeostasis supplying as much as 65% of
the caloric requirement as observed in patient 5 (Table 4).
Discussion
Although it has long been the practice to int'use large quanti-
ties of acetate into the bloodstream during hemodialysis, it is
surprising that no direct measurements of its rate of oxidation
have been made even though immediate oxidation is its as-
sumed metabolic fate [15]. Davidson et a! [2] measured the
percent recovery of infused radiolabeled acetate as 'tO2.
Since they did not determine both the plasma acetate and the
corrected expired carbon dioxide specific activities, the true
rate of acetate oxidation could not be determined in their study.
By applying standard radioisotope dilution techniques to deter-
mine the energy yield from dialysate acetate, the present study
provides for the first time a more complete quantitative descrip-
tion of the metabolic fate of the infused acetate and its effect on
energy metabolism.
The validity of the constant infusion radioistope dilution
technique is based on the establishment of a steady state which
in this ease is reflected by a constant plasma acetate specific
activity. As shown in Table 3, the criteria for steady state
conditions with respect to plasma acetate were met for the
determination of plasma acetate turnover and oxidation during
hemodialysis. In the determination of plasma acetate oxidation,
it can be argued that not all of the 42 production was derived
from [1— '4C] acetate oxidation but from isotope incorporated
into other substrates which were oxidized to form A
significant contribution of 4Q2 from the oxidation of sub-
strates other than acetate is unlikely because of the short
duration of the studies and the more rapid turnover of acetate
compared to substrates of greater molecular weight. Moreover,
the diversity of the potential pathways into which [l—'4C]
acetate can enter and undergo pool dilution renders the genera-
tion of significant quantities of '4C02 formation from other
substrates most improbable.
Our results indicated that plasma acetate underwent signifi-
cant oxidation to carbon dioxide. Since this data demonstrated
that acetate was a major energy source during hemodialysis, it
is probable that a reciprocal decrease in the oxidation of
another plasma substrate occurred to maintain energy homeo-
stasis. Karlsson, Fellenius, and Kiessling [16] showed in the
perfused hind quarter of the rat that acetate inhibited '4C-
palmitate oxidation. It is possible that the oxidation of plasma
acetate, a short-chain fatty acid, preferentially spared the
oxidation of long-chain fatty acids which could then become
esterified to triacylglycerides .
The theoretical RQ for the oxidation of acetate, like glucose,
is 1.0. Thus the overall RQ of 1.0 observed in these patients
indicated that fat oxidation was minimal during hemodialysis
and that net fat synthesis may have occurred. During acetate
hemodialysis without glucose, marked increases in free fatty
acids, ketone bodies and gluconeogenic precursors such as
lactic acid have been observed [1, 19] suggesting that fatty acids
are mobilized for energy and gluconeogenesis is stimulated.
J)uring acetate dialysis with glucose, however, we have not
observed elevations in the concentrations of these plasma
substrates which is eonsistant with the observed RQ of 1.0. It is
quite possible, therefore, that during acetate hemodialysis
without glucose the RQ is less than 1.0 and that endogenous
energy stores must be mobilized to meet the energy need,
Since the overall RQ was 1.0 and the RQ for protein is 0.8,
the nonprotein RQ must he greater than 1.0. By a kinetic
analysis of urea generation rates, Sargent et al [17] found that
the average protein catabolic rate was 1.1 g/kg/day in stable
chronic dialysis patients. In one of our patients (no. 5) the
protein catabolic rate, determined by urea kinetic analysis, was
1.0 glkglday. Assuming that 1.1 g/kg/day was the protein
catabolic rate typical of our patients, an average of 0.464 g of
protein nitrogen was generated per hour. To oxidize this
quantity of protein, 124 mmoles of oxygen are consumed and 98
mmoles of carbon dioxide are produced per hour which when
subtracted from the total oxygen consumption and carbon
dioxide production yields an average RQ of 1.05. Thus, the
combination of findings in this study consisting of an estimated
nonprotein RQ greater than 1.0 and the contribution from
acetate oxidation of 40% of the patient's caloric expenditure
-' In an unpublished study we observed in one patient during acetate
hemodialysis with glucose that long-chain plasma free fatty acid oxida-
tion accounted for less than 7% of the caloric expenditure.
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suggests that long-chain free fatty acid oxidation was reduced
and net fat synthesis occurred during dialysis.
If the oxidation of plasma acetate takes preference over long
chain fatty acid oxidation, the theoretical amount of long-chain
fatty acid spared by acetate oxidation and the net gain in fat can
be calculated. The energy yield from the oxidation of 473
mmoles or 28.4 g of acetate (caloric equivalence: 3.49 kcallg
acetate) is 99.1 kcal which is calorically equivalent to 11.0 g of
fat (caloric equivalence: 9 kcal!g fat) that would not be convert-
ed to long-chain free fatty acid for oxidation. In addition, 6 g of
fat could be synthesized from 258 mmoles of acetate that were
not oxidized immediately to carbon dioxide. A patient, there-
fore, has the potential to gain 18 g of fat during 4 hr of dialysis
from the combined sparing effect of acetate on free fatty acid
oxidation and the synthesis of fat from acetate. This is a
significant gain in fat and is equivalent to the amount of free
fatty acid oxidized in the basal state by nonuremic subjects [61.
The potential to gain 18 g of fat during dialysis may be a
conservative estimate because a nonprotein RQ above unity
implies that carbohydrate is transformed into fat [18]. This
usually occurs when there is an overabundance of carbohy-
drate. During acetate dialysis with glucose, Wathen et al [19]
showed that glucose readily diffuses into the bloodstream. In an
unpublished study, we found in patients hemodialyzed as
described in Methods that 422.8 18.0 /Lmoles (mean SEM) of
glucose enter the bloodstream per minute. Hence, in addition to
acetate, the patient must eliminate a large quantity of dialysate
glucose. In view of the nonprotein RQ above 1.0 and the high
insulin levels accompanying acetate dialysis with glucose [191,
the dialysate glucose which is not utilized for energy is probably
converted to fat.
If acetate and glucose oxidation preempts fat consumption as
suggested in this study, then replacement of acetate in the
dialysate with bicarbonate should result in changes in plasma
lipid profiles. Indeed, recent studies [20, 21] have shown that
plasma triglyceride levels improve significantly during bicar-
bonate dialysis, but return to high levels when acetate is
reinstituted in the dialysis fluid [22]. In patient's whose basal
triglyceride levels were elevated, Daubresse et al [23] observed
no change in the plasma triglyceride concentration after pro-
longed acetate hemodialysis without glucose; however, there
was a marked increase in those patients undergoing acetate
hemodialysis with glucose. The present studies do not provide
direct evidence for net fat synthesis during dialysis with dialysis
fluid containing acetate and glucose. However, they do provide
a quantitative basis to show that excess carbon skeletons are
available for fat synthesis due to a sparing effect resulting from
preferential acetate oxidation.
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